Electrophysiological Biomarkers of AV-101

NCT03583554 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Placebo
DRUG: AV-101 720 mg
DRUG: AV-101 1440 mg

Sponsor

Marijn Lijffijt, PhD

Collaborators

[object Object]
[object Object]